Dacomitinib
56 interactions 1 explained in plain English 55 cited referencesDacomitinib is used to treat a certain type of non-small-cell lung cancer (NSCLC) that has spread to other parts of the body. Dacomitinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the sprea… Read the full Dacomitinib drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Moderate
Dacomitinib Trospium / Xanomeline Cobenfy Explained Increased xanomeline exposure and an increased risk on severity and frequency of xanomeline-related adverse reactions Details Dacomitinib Levothyroxine Ermeza Increased risk of hypothyroidism Details Dacomitinib Xanomeline Increased xanomeline exposure and an increased risk on severity and frequency of xanomeline-related adverse reactions DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist